Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET

被引：4
|
作者：
Hardie, RJ [1 ]
机构：
[1] Atkinson Morleys Hosp, Reg Neurosci Unit, Wolfson Neurorehabil Ctr, St Georges Healthcare, London SW20 0NE, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1999年 / 66卷 / 02期
关键词：
D O I：
10.1136/jnnp.66.2.256
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [31] Longitudinal comparison of 11C-PE2I and 18F-DOPA PET for assessing severity and rate of disease progression in patients with Parkinson's disease
    Li, W.
    Lao-Kaim, N.
    Roussakis, A. -A.
    Martin-Bastida, A.
    Loane, C.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Politis, M.
    Foltynie, T.
    Barker, R.
    Piccini, P.
    [J]. MOVEMENT DISORDERS, 2017, 32
  • [32] Progression in Parkinson's disease. An 18F-FDOPA PET study
    Juri, C.
    Aibizu, J.
    Rodriguez-Oroz, M.
    Prieto, E.
    Marti, J. M.
    Richter, J.
    Obeso, J.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S60 - S60
  • [33] 11C-PE2I and 18F-DOPA PET imaging for assessing the severity and rate of progression in Parkinson's disease: The longitudinal study
    Li, W.
    Lao-Kaim, N.
    Roussakis, A.
    Martin-Bastida, A.
    Valle-Guzman, N.
    Loane, C.
    Kefalopoulou, Z.
    Politis, M.
    Foltynie, T.
    Barker, R.
    Piccini, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 593 - 593
  • [34] 11C-PE2I and 18F-Dopa PET for Assessing Progression Rate in Parkinson's: A Longitudinal Study
    Li, Weihua
    Lao-Kaim, Nick P.
    Roussakis, Andreas A.
    Martin-Bastida, Antonio
    Valle-Guzman, Natalie
    Paul, Gesine
    Loane, Clare
    Widner, Hakan
    Politis, Marios
    Foltynie, Tom
    Barker, Roger A.
    Piccini, Paola
    [J]. MOVEMENT DISORDERS, 2018, 33 (01) : 117 - 127
  • [35] Extrastriatal monoamine neuron function in Parkinson's disease:: An 18F-dopa PET study
    Moore, Robert Y.
    Whone, Alan L.
    BrookSa, David J.
    [J]. NEUROBIOLOGY OF DISEASE, 2008, 29 (03) : 381 - 390
  • [36] A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease
    Hu, MTM
    White, SJ
    Herlihy, AH
    Chaudhuri, KR
    Hajnal, JV
    Brooks, DJ
    [J]. NEUROLOGY, 2001, 56 (09) : 1195 - 1200
  • [37] Striatal and extrastriatal dysfunction in Parkinson's disease with dementia. A 6-[18F]fluoro-l-dopa PET study
    Ito, K
    Nagano-Saito, A
    Kato, T
    Arahata, Y
    Nakamura, A
    Kawasumi, Y
    Hatano, K
    Abe, Y
    Yamada, T
    Kachi, T
    Brooks, DJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1089 - 1089
  • [38] [18F]FAZIN3: A novel PET imaging agent for Parkinson's Disease
    Phuc Lam
    Martinez, Stephanie
    Patel, Krystal
    Liang, Christopher
    Mukherjee, Jogeshwar
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] Diagnostic value of striatal [18F]-FP-DTBZ PET in Parkinson's disease
    Liu, X.
    Liu, S.
    Barret, O.
    Tamagnan, G.
    Qiao, H.
    Song, T.
    Lu, J.
    Piu, C.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (1_SUPPL): : 136 - 136
  • [40] [18F]FDG PET/CT Studies in Parkinson's Disease Mouse Model of α-Syncleinopathy
    Campoy, Anthony
    Mondal, Rommani
    Liang, Christopher
    Mukherjee, Jogeshwar
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
12345